Diametric Capital’s Burning Rock Biotech BNR Stock Holding History

Diametric Capital’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,783	Closed	-$27K	–	277
2023 Q3	$27K	Sell	2,783 -1,447	-34%	-$22.6K	0.01%	317
2023 Q2	$90.9K	Sell	4,230 -1,525	-26%	-$40.5K	0.04%	285
2023 Q1	$162K	Sell	5,755 -3,465	-38%	-$104K	0.08%	238
2022 Q4	$207K	Sell	9,220 -22,756	-71%	-$519K	0.1%	237
2022 Q3	$764K	Buy	31,976 +20,975	+191%	+$677K	0.39%	95
2022 Q2	$320K	Buy	+11,001	New	+$491K	0.24%	150

Other funds holding BNR

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return

Diametric Capital's BNR Position: Q4 2023 in Review

Diametric Capital sold out of Burning Rock Biotech (BNR) in Q4 2023, closing a stake of 2,783 shares — an estimated $27K sold.

Diametric Capital first reported a position in BNR in Q2 2022 and held it in 6 quarters. The position peaked at $764K in Q3 2022. 19 funds tracked by Wall St. Rank hold BNR as of Q4 2023.

Diametric Capital reported no remaining Burning Rock Biotech position as of Q4 2023 after selling out during the quarter.
Diametric Capital sold 2,783 Burning Rock Biotech shares in Q4 2023, an estimated $27K.
Diametric Capital first reported a position in Burning Rock Biotech in Q2 2022 and held it in 6 quarters.
Diametric Capital's Burning Rock Biotech position peaked at $764K in Q3 2022.
19 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2023.

Based on Diametric Capital's 13F filing for Q4 2023, filed 13 Feb 2024.